Literature DB >> 239474

Purification and characterization of guinea pig lymphotoxin produced by lymph node cells stimulated by phytohemagglutinin.

J I Sawada, K Shioiri-Nakano, T Osawa.   

Abstract

Guinea pig lymphotoxin (LT) produced by stimulation of lymph node cells with Phaseolus vulgaris phytohemagglutinin was purified approximately 1,000-fold in specific activity by ammonium sulfate fractionation, DEAE-Sephadex column chromatography, and gel filtration on Sephadex G-100. The properties of LT tested at the various stages of purification revealed that the LT was a heat-sensitive, protease-sensitive proteinaceous substance, and its approximate molecular weight was estimated to be 50,000 by means of gel filtration. The most purified fraction (Fr. D) was found to be devoid of the activities of migration inhibitory and mitogenic factors, clearly indicating that these activities are mediated by different substances.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 239474     DOI: 10.1097/00007890-197504000-00009

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Identity of human B-cell line cytotoxic lymphokine with tumor necrosis factor type beta.

Authors:  H I Yamanaka; A Karpas
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

2.  Guinea-pig lymphotoxin resistant L-cell sublines.

Authors:  Y Kobayashi; J Sawada; T Osawa
Journal:  Immunology       Date:  1979-01       Impact factor: 7.397

Review 3.  Lymphotoxin. A review and analysis.

Authors:  W Rosenau; C D Tsoukas
Journal:  Am J Pathol       Date:  1976-09       Impact factor: 4.307

4.  Macrophage-mediated cytotoxicity: role of a soluble macrophage cytotoxic factor similar to lymphotoxin and tumor necrosis factor.

Authors:  C M Zacharchuk; B E Drysdale; M M Mayer; H S Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

5.  Guinea-pig lymphotoxin-mediated cytotoxicity and activation of endogenous phospholipase A2.

Authors:  H Yagisawa; T Osawa
Journal:  Immunology       Date:  1982-11       Impact factor: 7.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.